Return On Assets in % of NEXIEN BIOPHARMA, INC. from 2017 to Q1 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NEXIEN BIOPHARMA, INC. quarterly/annual Return On Assets history and change rate from 2017 to Q1 2025.
  • NEXIEN BIOPHARMA, INC. Return On Assets for the quarter ending 31 Mar 2025 was -40 %, a 235% decline year-over-year.
  • NEXIEN BIOPHARMA, INC. annual Return On Assets for 2024 was -22 %, a 334% decline from 2023.
  • NEXIEN BIOPHARMA, INC. annual Return On Assets for 2023 was -5 %, a 43.1% increase from 2022.
  • NEXIEN BIOPHARMA, INC. annual Return On Assets for 2022 was -8 %, a 84.3% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2025 -40 -28 -2.3% 01 Jan 2025 31 Mar 2025
Q4 2024 -34 -26 -2.9% 01 Oct 2024 31 Dec 2024
Q3 2024 -30 -23 -3.4% 01 Jul 2024 30 Sep 2024
Q2 2024 -22 -17 -3.3% 01 Apr 2024 30 Jun 2024
Q1 2024 -12 -8 -2% 01 Jan 2024 31 Mar 2024
Q4 2023 -8 -4 -1.1% 01 Oct 2023 31 Dec 2023
Q3 2023 -6 -0 -7.2% 01 Jul 2023 30 Sep 2023
Q2 2023 -5 +4 +43.1% 01 Apr 2023 30 Jun 2023
Q1 2023 -4 +12 +74.6% 01 Jan 2023 31 Mar 2023
Q4 2022 -4 +14 +76.6% 01 Oct 2022 31 Dec 2022
Q3 2022 -6 +24 +79.1% 01 Jul 2022 30 Sep 2022
Q2 2022 -8 +48 +84.3% 01 Apr 2022 30 Jun 2022
Q1 2022 -15 +58 +78.6% 01 Jan 2022 31 Mar 2022
Q4 2021 -17 +41 +69.6% 01 Oct 2021 31 Dec 2021
Q3 2021 -30 +9 +22.5% 01 Jul 2021 30 Sep 2021
Q2 2021 -57 -35 -1.6% 01 Apr 2021 30 Jun 2021
Q1 2021 -73 -58 -3.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -59 -51 -6% 01 Oct 2020 31 Dec 2020
Q3 2020 -39 -31 -3.9% 01 Jul 2020 30 Sep 2020
Q2 2020 -21 -16 -2.7% 01 Apr 2020 30 Jun 2020
Q1 2020 -15 -12 -3.4% 01 Jan 2020 31 Mar 2020
Q4 2019 -8 -5 -1.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -7 -7 -4.7% 01 Jul 2019 30 Sep 2019
Q2 2019 -5 -4 -3.1% 01 Apr 2019 30 Jun 2019
Q1 2019 -3 -2 -1.3% 01 Jan 2019 31 Mar 2019
Q4 2018 -3 -1 -45.4% 01 Oct 2018 31 Dec 2018
Q3 2018 -1 +2 +62.1% 01 Jul 2018 30 Sep 2018
Q2 2018 -1 -0 -1.2% 01 Apr 2018 30 Jun 2018
Q1 2018 -1 01 Jan 2018 31 Mar 2018
Q4 2017 -2 01 Oct 2017 31 Dec 2017
Q3 2017 -3 01 Jul 2017 30 Sep 2017
Q2 2017 -1 27 Mar 2017 30 Jun 2017

NEXIEN BIOPHARMA, INC. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -22 -17 -3.3% 01 Jul 2023 30 Jun 2024
2023 -5 +4 +43.1% 01 Jul 2022 30 Jun 2023
2022 -8 +48 +84.3% 01 Jul 2021 30 Jun 2022
2021 -57 -35 -1.6% 01 Jul 2020 30 Jun 2021
2020 -21 -16 -2.7% 01 Jul 2019 30 Jun 2020
2019 -5 -4 -3.1% 01 Jul 2018 30 Jun 2019
2018 -1 -1 -11.6% 01 Jul 2017 30 Jun 2018
2017 0 01 Jul 2016 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.